MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2024 International Congress

    The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy

    P. Alster, D. Otto-ślusarczyk, A. Drzewińska, K. Duszyńska-Wąs, A. Wiercińska-Drapało, M. Struga, N. Madetko-Alster (Warszawa, Poland)

    Objective: The goal of the research was to verify the possible association between the levels of inflammatory factors and frontal deficits in Progressive Supranuclear Palsy…
  • 2024 International Congress

    Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy

    A. Blazek, C. Hogen, J. Whitwell, K. Josephs, K. Kaufman, F. Ali (Rochester, USA)

    Objective: To evaluate the validity and precision of using inertial measurement units (IMU) for measurement of kinematics and spatial-temporal features of gait in progressive supranuclear…
  • 2024 International Congress

    Linear Mixed-Effect Modelling of Antisaccades in Parkinson’s Disease and Progressive Supranuclear Palsy

    S. Patel, O. Patel, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate variations in antisaccade parameters (latency, damping ratio, peak velocity, and amplitude) among different stages of Parkinson's Disease (PD), Progressive…
  • 2024 International Congress

    Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment

    D. Taniguchi, T. Hatano, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: This study monitored the formation of CBD (corticobasal degeneration)-type fibrils that exhibit astrocytic plaques, a characteristic CBD pathology, using Legumain-cleavage site-specific antibodies and CBD-specific…
  • 2024 International Congress

    Peripheral inflammation severity in differential diagnosis of progressive supranuclear palsy and multiple system atrophy – usefulness of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and neutrophil-to-high-density lipoprotein-cholesterol ratio

    N. Madetko-Alster, B. Migda, P. Chunowski, P. Alster (Warsaw, Poland)

    Objective: Assessment of the possible differences in peripheral inflammation severity between progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) with the use of three…
  • 2024 International Congress

    Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

    D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)

    Objective: The objective of this study was to explore atypical features in the clinical phenotype of people with Parkinson’s disease (PwP) enrolled in the East…
  • 2024 International Congress

    Can Square Wave Jerks Differentiate Progressive Supranuclear Palsy from Parkinson’s Disease? A Scoping Review

    Y. Xu, N. Bellacicco, E. Feinstein (Newark, USA)

    Objective: To review the available literature regarding the presence and properties of square wave jerks (SWJs) in Progressive Supranuclear Palsy (PSP) and Parkinson’s Disease (PD).…
  • 2024 International Congress

    Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation

    N. Olfati, S. Akhlaghi, A. Shoeibi, I. Litvan (San Diego, USA)

    Objective: PSP-P is the second most common PSP phenotype. To facilitate its inclusion in future clinical trials, we used longitudinal data from the TAUROS study…
  • 2024 International Congress

    Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: : To investigate cholinergic brain regional differences between Progressive supranuclear palsy with parkinsonism (PSP-P) and Parkinson's disease (PD), using the highly selective radiotracer for…
  • 2024 International Congress

    Bedside Assessment of Downgaze Palsy by Amplitude in Patients with Progressive Supranuclear Palsy

    T. Xie, M. Padmanaban, W. Abou Chaar, J. Nichols (Chicago, USA)

    Objective: To assess the specificity and reliability of the bedside assessment of downgaze palsy by amplitude based on the upper edge of the iris relative to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 38
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley